Vinblastine Other names: Vincoblastine Vincaleucoblastine Vincaleukoblastine

Chemical formula: C₄₆H₅₈N₄O₉  Molecular mass: 810.974 g/mol  PubChem compound: 13342

Therapeutic indications

Vinblastine is indicated for:

Indication

Population group: only adults (18 years old or older)

at least one of
Hodgkin's disease
Follicular [nodular] non-Hodgkin's lymphoma
Diffuse non-Hodgkin's lymphoma
Other and unspecified types of non-Hodgkin's lymphoma
Mycosis fungoides
Kaposi's sarcoma
Letterer-Siwe disease
Renal cell carcinoma

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: women, only adults (18 years old or older)

Malignant neoplasm of breast

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: men, only adults (18 years old or older)

Malignant neoplasm of testis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: women, only adults (18 years old or older)

Malignant neoplasm of placenta

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Vinblastine is contraindicated in the following cases:

Contraindication

at least one of
Leukopenia
Other nonthrombocytopenic purpura
Idiopathic thrombocytopenic purpura
Other primary thrombocytopenia
Secondary thrombocytopenia
Thrombocytopenia, unspecified
Pregnancy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.